Ocean Biomedical, Inc. (OCEAW)
USD 0.03
(-8.31%)
USD 0.03
(-8.31%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Cash Flow | -747.29 Thousand | -1.05 Million | -64 Thousand | - |
| Net Income | -958.43 Thousand | -62.34 Million | -1.65 Million | -232 Thousand |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | 56.55 Million | - | - |
| Change in working capital | 1.73 Million | 4.74 Million | 1.58 Million | 232 Thousand |
| Other non-cash items | -1.52 Million | -2449.00 | - | - |
| Investing Cash Flow | -2.1 Million | -107.1 Million | - | - |
| Investments in PPE | -3.00 | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | -2.1 Million | -107.1 Million | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -2.1 Million | - | - | - |
| Financing Cash Flow | 2.1 Million | 1.11 Million | 64 Thousand | - |
| Debt repayment | -2.1 Million | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | 1.01 Million | - | - |
| Other Financing Activities | 4.2 Million | 96 Thousand | 64 Thousand | - |
| Accounts receivables | - | - | - | - |
| Accounts payables | 290.38 Thousand | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | 1.44 Million | 4.74 Million | - | - |
| Cash at beginning of period | 1.07 Million | - | - | - |
| Cash at end of period | 328.3 Thousand | 60 Thousand | - | - |
| Capital Expenditure | -3.00 | - | - | - |
| Effect of forex changes on cash | - | 107.1 Million | - | - |
| Net cash flow / Change in cash | -747.29 Thousand | 60 Thousand | - | - |
| Free Cash Flow | -747.3 Thousand | -1.05 Million | -64 Thousand | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.08 Million | -13.02 Million | -67.4 Million | -958.43 Thousand | 410.05 Thousand | -1.01 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 186 Thousand | 186 Thousand | 646 Thousand | - | - | 2.93 Million |
| Change in working capital | 1.58 Million | -1.42 Million | 1.92 Million | 1.73 Million | 471.06 Thousand | 1.05 Million |
| Other non-cash items | 11.19 Million | 9.48 Million | 62.17 Million | -1.52 Million | -1.02 Million | -351.77 Thousand |
| Investing Cash Flow | - | - | - | -2.1 Million | -1.05 Million | -1.05 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -2.1 Million | -1.05 Million | -1.05 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -2.1 Million | - | - |
| Financing Cash Flow | - | 6.63 Million | 2.92 Million | 2.1 Million | 1.05 Million | 1.25 Million |
| Debt repayment | - | -1.55 Million | -550 Thousand | -2.1 Million | -1.05 Million | -1.05 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -51.6 Million | - | -12.67 Million | - | - | - |
| Common Stock Issuance | - | 52.07 Million | 14.26 Million | - | - | 209.13 Thousand |
| Other Financing Activities | 51.6 Million | -43.88 Million | 1.88 Million | 4.2 Million | - | 137 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.53 Million | -1.26 Million | 1.44 Million | 290.38 Thousand | -1.92 Million | -142 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 41 Thousand | -163 Thousand | 482 Thousand | 1.44 Million | 471.06 Thousand | 1.05 Million |
| Cash at beginning of period | 2.16 Million | 306 Thousand | 34 Thousand | 1.07 Million | 472.1 Thousand | 576.75 Thousand |
| Cash at end of period | 1.03 Million | 2.16 Million | 306 Thousand | 328.3 Thousand | 328.3 Thousand | 472.1 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.13 Million | 1.85 Million | 272 Thousand | -747.29 Thousand | -143.8 Thousand | -104.65 Thousand |
| Free Cash Flow | -1.13 Million | -4.78 Million | -2.65 Million | -747.29 Thousand | -143.8 Thousand | -313.78 Thousand |
CYIENT
ROOPAIND
6222
OWLI
BBOX
URGN